{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:22:11Z","timestamp":1759335731356},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T00:00:00Z","timestamp":1358467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s15010-012-0399-2","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T07:57:11Z","timestamp":1358409431000},"page":"719-722","source":"Crossref","is-referenced-by-count":6,"title":["Chryseomonas luteola bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy"],"prefix":"10.1007","volume":"41","author":[{"given":"A. Y.","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. K.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. B.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,18]]},"reference":[{"key":"399_CR1","first-page":"170","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","unstructured":"Centers for Disease Control and Prevention. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension\u2014seven sites, United States, 2003\u20132006. MMWR Morb Mortal Wkly Rep. 2007;56:170\u20132.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"399_CR2","doi-asserted-by":"crossref","first-page":"56S","DOI":"10.1016\/j.jacc.2004.02.036","volume":"43","author":"DB Badesch","year":"2004","unstructured":"Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:56S\u201361S.","journal-title":"J Am Coll Cardiol"},{"key":"399_CR3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, J\u00f6bsis MM, Blackburn SD Jr, Crow JW, Long WA. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296\u2013302.","journal-title":"N Engl J Med"},{"key":"399_CR4","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","volume":"94","author":"BM Forman","year":"1997","unstructured":"Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA. 1997;94:4312\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"399_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0735-1097(97)00187-3","volume":"30","author":"SM Shapiro","year":"1997","unstructured":"Shapiro SM, Oudiz RJ, Cao T, Romano MA, Beckmann XJ, Georgiou D, Mandayam S, Ginzton LE, Brundage BH. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol. 1997;30:343\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"399_CR6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.mop.0000163356.51027.c1","volume":"17","author":"EB Rosenzweig","year":"2005","unstructured":"Rosenzweig EB, Barst RJ. Idiopathic pulmonary arterial hypertension in children. Curr Opin Pediatr. 2005;17:372\u201380.","journal-title":"Curr Opin Pediatr"},{"key":"399_CR7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI113346","volume":"81","author":"P Libby","year":"1988","unstructured":"Libby P, Warner SJ, Friedman GB. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest. 1988;81:487\u201398.","journal-title":"J Clin Invest"},{"key":"399_CR8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1378\/chest.11-0245","volume":"141","author":"JD Rich","year":"2012","unstructured":"Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M. The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest. 2012;141:36\u201342.","journal-title":"Chest"},{"key":"399_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00109-010-0694-2","volume":"89","author":"CH Kuo","year":"2011","unstructured":"Kuo CH, Ko YC, Yang SN, Chu YT, Wang WL, Huang SK, Chen HN, Wei WJ, Jong YJ, Hung CH. Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation. J Mol Med (Berl). 2011;89:29\u201341.","journal-title":"J Mol Med (Berl)."},{"key":"399_CR10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1742-1241.2009.02307.x","volume":"64","author":"D Zaccardelli","year":"2010","unstructured":"Zaccardelli D, Phares K, Jeffs R, Doran A, Wade M. Stability and antimicrobial effectiveness of treprostinil sodium in sterile diluent for flolan. Int J Clin Pract. 2010;64:885\u201391.","journal-title":"Int J Clin Pract"},{"key":"399_CR11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1099\/00207713-35-4-467","volume":"35","author":"K Kodama","year":"1985","unstructured":"Kodama K, Kimura N, Komagata K. Two new species of Pseudomonas: P. oryzihabitans isolated from rice paddy and clinical specimens and P. luteola isolated from clinical specimens. Int J Syst Bacteriol. 1985;35:467\u201374.","journal-title":"Int J Syst Bacteriol"},{"key":"399_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00005792-199503000-00003","volume":"74","author":"G Rahav","year":"1995","unstructured":"Rahav G, Simhon A, Mattan Y, Moses AE, Sacks T. Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2). Medicine (Baltimore). 1995;74:83\u20138.","journal-title":"Medicine (Baltimore)"},{"key":"399_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/clinids\/13.2.233","volume":"13","author":"JR Kostman","year":"1991","unstructured":"Kostman JR, Solomon F, Fekete T. Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients. Rev Infect Dis. 1991;13:233\u20136.","journal-title":"Rev Infect Dis"},{"key":"399_CR14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/INF.0b013e3181bd8158","volume":"28","author":"A Gaschet","year":"2009","unstructured":"Gaschet A, Engrand C, Piau C, Violette J, B\u00e9tr\u00e9mieux P, Tattevin P, Pladys P, Donnio PY, Jolivet-Gougeon A. Multiple brain abscesses caused by Pseudomonas luteola. Pediatr Infect Dis J. 2009;28:1144\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"399_CR15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1128\/JCM.42.4.1837-1839.2004","volume":"42","author":"W Chihab","year":"2004","unstructured":"Chihab W, Alaoui AS, Amar M. Chryseomonas luteola identified as the source of serious infections in a Moroccan University Hospital. J Clin Microbiol. 2004;42:1837\u20139.","journal-title":"J Clin Microbiol"},{"key":"399_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0732-8893(98)00082-0","volume":"32","author":"S Rastogi","year":"1998","unstructured":"Rastogi S, Sperber SJ. Facial cellulitis and Pseudomonas luteola bacteremia in an otherwise healthy patient. Diagn Microbiol Infectious Dis. 1998;32:303\u20135.","journal-title":"Diagn Microbiol Infectious Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-012-0399-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-012-0399-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-012-0399-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T17:38:03Z","timestamp":1559497083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-012-0399-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,18]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1007\/s15010-012-0399-2","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,18]]}}}